Fraunhofer USA Center for Molecular Biotechnology
Dr. Vidadi Yusibov, Executive Director

9 Innovation Way, Suite 200
Newark, DE 19711

phone: 302-369-1708
fax: 302-369-8955
website: www.fraunhofer-cmb.org
e-mail: vyusibov@fraunhofer-cmb.org

A non-profit contract research organization, the Fraunhofer Center for Molecular Biotechnology (CMB) emphasizes discovery and development of processes for making proteins in plants for use in vaccines, therapeutic proteins or enzymes. Research activities include the use of synthetic vectors to cause the expression of peptides and proteins in plants, in addition to protein engineering and high throughput screening of modified proteins. Currently, CMB is developing a complete protocol for medium and large-scale production of proteins in plants, including recovery and purification.

CMB’s research contracts include the development system component for a diagnostic test to predict juvenile diabetes, sponsored by the Delaware State Department of Health; human hormone proteins for a private sponsor; and a Navy contract for preliminary work on a vaccine.

Press Release: January 25, 2005
Press Release: January 14, 2004
Press Release: January 13, 2004